$Aprea Therapeutics (APRE.US)$ Item 8.01Other Events. On Oct...
$Aprea Therapeutics(APRE.US$ Item 8.01Other Events.
On October 16, 2023, Aprea Therapeutics, Inc. issued a press release announcing initial clinical data on ATRi, ATRN-119, and pre-clinical data on WEE1i, ATRN-1051, presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, supporting highly differentiated synthetic lethality portfolio. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated herein by reference.![]()
On October 16, 2023, Aprea Therapeutics, Inc. issued a press release announcing initial clinical data on ATRi, ATRN-119, and pre-clinical data on WEE1i, ATRN-1051, presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, supporting highly differentiated synthetic lethality portfolio. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated herein by reference.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
